131 related articles for article (PubMed ID: 10971401)
1. Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy.
Parez N; Dommergues M; Zupan V; Chambost H; Fieschi JB; Delaunay J; Miélot F; Cramer EM; Dommergues JP; Wickramasinghe SN; Tchernia G
Br J Haematol; 2000 Aug; 110(2):420-3. PubMed ID: 10971401
[TBL] [Abstract][Full Text] [Related]
2. Treatment of transfusion-dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha-2a.
Abu-Quider A; Asleh M; Shalev H; Fruchtman Y; Ben-Harosh M; Beck G; Kapelushnik J
Eur J Haematol; 2020 Aug; 105(2):216-222. PubMed ID: 32302424
[TBL] [Abstract][Full Text] [Related]
3. Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b.
Roda L; Pasche J; Fournier A; Terorotua V; Wickramasinghe SN; Tamary H; Schischmanoff PO; Tchernia G; Delaunay J
J Pediatr Hematol Oncol; 2002; 24(6):503-6. PubMed ID: 12218603
[TBL] [Abstract][Full Text] [Related]
4. alpha-Interferon therapy for congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Blanc P; Navarro R; Saghroun M; Vannereau H; Braun M; Wagner A; Taïb J; Lavabre-Bertrand C; Navarro M
Br J Haematol; 1995 Apr; 89(4):929-32. PubMed ID: 7772538
[TBL] [Abstract][Full Text] [Related]
5. Congenital dyserythropoietic anemia type 1 with fetal onset of severe anemia.
Kato K; Sugitani M; Kawataki M; Ohyama M; Aida N; Koga N; Ijiri R; Imaizumi K; Kigasawa H; Tanaka Y; Itani Y
J Pediatr Hematol Oncol; 2001 Jan; 23(1):63-6. PubMed ID: 11196275
[TBL] [Abstract][Full Text] [Related]
6. An Unusual Hydrops Fetalis Associated with Compound Heterozygosity for Krüppel-like Factor 1 mutations.
Lee HH; Mak AS; Kou KO; Poon CF; Wong WS; Chiu KH; Au PK; Chan KY; Kan AS; Tang MH; Leung KY
Hemoglobin; 2016 Nov; 40(6):431-434. PubMed ID: 28361594
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.
Roy NBA; Babbs C
Br J Haematol; 2019 May; 185(3):436-449. PubMed ID: 30836435
[TBL] [Abstract][Full Text] [Related]
8. Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.
Yarali N; Fişgin T; Duru F; Atilla P; Müftüoğlu SF; Kaymaz SF
Pediatr Hematol Oncol; 2005 Jun; 22(4):265-70. PubMed ID: 16020112
[TBL] [Abstract][Full Text] [Related]
9. Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
Molad M; Waisman D; Rotschild A; Auslander R; Kessel I; Soloviechick M; Goldberg Y; Shabad E
J Perinatol; 2013 Jun; 33(6):490-1. PubMed ID: 23719252
[TBL] [Abstract][Full Text] [Related]
10. Congenital dyserythropoietic anaemia: report of three cases.
Ariffin WA; Karnaneedi S; Choo KE; Normah J
J Paediatr Child Health; 1996 Apr; 32(2):191- 3. PubMed ID: 9156534
[TBL] [Abstract][Full Text] [Related]
11. A severe transfusion-dependent congenital dyserythropoietic anaemia presenting as hydrops fetalis.
Cantù-Rajnoldi A; Zanella A; Conter U; Faccini P; Soligo D; Gornati G; Vegni C; Nicolini U
Br J Haematol; 1997 Mar; 96(3):530-3. PubMed ID: 9054660
[TBL] [Abstract][Full Text] [Related]
12. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Ramos J; Delfour C; Henry L; Guiraud I; Carillo S; Wagner A; Bureau JP; Blanc P
Eur J Haematol; 2004 Nov; 73(5):380-3. PubMed ID: 15458519
[TBL] [Abstract][Full Text] [Related]
13. Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.
Rathe M; Møller MB; Greisen PW; Fisker N
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049846
[TBL] [Abstract][Full Text] [Related]
14. Transfusion-dependent congenital dyserythropoietic anaemia with intraerythroblastic inclusions of a non-globin protein.
Iolascon A; Martire B; Lee MJ; Wickramasinghe SN
Eur J Haematol; 2000 Aug; 65(2):140-3. PubMed ID: 10966176
[TBL] [Abstract][Full Text] [Related]
15. Response of CDA type I to alpha-interferon.
Wickramasinghe SN
Eur J Haematol; 1997 Feb; 58(2):121-3. PubMed ID: 9111594
[No Abstract] [Full Text] [Related]
16. Congenital dyserythropoietic anaemias: splenectomy as a mode of therapy.
Choudhry VP; Saraya AK; Kasturi J; Rath PK
Acta Haematol; 1981; 66(3):195-201. PubMed ID: 6795878
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine therapy in a fetus with congenital dyserythropoietic anaemia type I.
Lin SM; Chen M; Ma ES; Lam YH; Wong KY; Tang MH
J Obstet Gynaecol; 2014 May; 34(4):352-3. PubMed ID: 24724939
[No Abstract] [Full Text] [Related]
18. Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I.
Shamseddine A; Taher A; Jaafar H; Haidar JH; Nasr R; Arzoumanian V; Salem Z; Bazarbachi A
Eur J Haematol; 2000 Sep; 65(3):207-9. PubMed ID: 11007058
[TBL] [Abstract][Full Text] [Related]
19. Congenital dyserythropoiesis type I and alpha-interferon therapy.
Virjee S; Hatton C
Br J Haematol; 1996 Sep; 94(3):581-2. PubMed ID: 8790164
[No Abstract] [Full Text] [Related]
20. The diagnostic challenge of congenital dyserythropoietic anaemia: two cases of 'CDA type II'.
Dukka S; King MJ; Hill QA
J Clin Pathol; 2014 Apr; 67(4):367-9. PubMed ID: 24385490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
